Literature DB >> 9466521

Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects.

G Boivin1, J Handfield, E Toma, G Murray, R Lalonde, M G Bergeron.   

Abstract

The cytomegalovirus (CMV) DNA load was determined in polymorphonuclear leukocytes (PMNL) and plasma samples from 106 human immunodeficiency virus-infected subjects at risk of developing CMV disease (group 1) and from 27 AIDS patients with documented CMV disease (group 2). For both groups, the number of CMV copies in PMNL was significantly higher than in plasma when results were derived from an equivalent blood volume (P < .001, PMNL vs. plasma). Additionally, group 2 (symptomatic) patients had a greater viral DNA load than group 1 (asymptomatic) subjects (P < .001 for both PMNL and plasma). The sensitivity, specificity, and positive and negative predictive values of qualitative polymerase chain reaction using PMNL (PCR-PMNL) for the presence of CMV disease were 100%, 58%, 38%, and 100%, respectively, compared with 70%, 93%, 74%, and 92% for qualitative PCR-plasma and 93%, 92%, 76%, and 98% for quantitative PCR-PMNL using a cutoff of 16,000 copies/mL. Thus, the best strategy for diagnosing CMV disease in these individuals relies on quantitative assessment of the viral DNA load in PMNL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466521     DOI: 10.1086/514190

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Enhanced analytical sensitivity of a quantitative PCR for CMV using a modified nucleic-acid extraction procedure.

Authors:  A Ferreira-Gonzalez; S Yanovich; M R Langley; L A Weymouth; D S Wilkinson; C T Garrett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.

Authors:  B S Blank; P L Meenhorst; J W Mulder; G J Weverling; H Putter; W Pauw; W C van Dijk; P Smits; S Lie-A-Ling; P Reiss; J M Lange
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA.

Authors:  Angela M Caliendo; Belinda Yen-Lieberman; Jovana Baptista; Janet Andersen; Clyde Crumpacker; Rob Schuurman; Stephen A Spector; James Bremer; Nell S Lurain
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Authors:  Michael Boeckh; MeeiLi Huang; James Ferrenberg; Terry Stevens-Ayers; Laurence Stensland; W Garrett Nichols; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented.

Authors:  René Boom; Cees J A Sol; Tim Schuurman; Alex Van Breda; Jan F L Weel; Marcel Beld; Ineke J M Ten Berge; Pauline M E Wertheim-Van Dillen; Menno D De Jong
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.

Authors:  G Boivin; R Bélanger; R Delage; C Béliveau; C Demers; N Goyette; J Roy
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; M Forman; C Enger; J B Jackson
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

9.  False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation.

Authors:  P Schäfer; W Tenschert; M Schröter; K Gutensohn; R Laufs
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

10.  Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation.

Authors:  Marcy L Vana; Danuse Formankova; Steven Cha; Anjali Sharma; Luciano Potena; Janice M Y Brown; Edward S Mocarski
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.